Introduction:
The biologics market in Mexico is experiencing rapid growth, driven by increasing demand for innovative treatments and advancements in biotechnology. According to industry reports, the market size for biologics in Mexico is expected to reach $2.5 billion by 2026. As the industry continues to expand, it is crucial to identify the top players in the market. Here we unveil the top 30 premier biologic companies in Mexico for 2026.
Top 30 Premier Biologic Companies in Mexico 2026:
1. Genentech Mexico
– Market share: 15%
– Genentech Mexico is a leading biotech company known for its innovative biologic treatments for cancer and autoimmune diseases.
2. Novartis Biologics Mexico
– Market share: 12%
– Novartis Biologics Mexico is a key player in the Mexican biologics market, offering a wide range of biologic therapies for various medical conditions.
3. AbbVie Mexico
– Market share: 10%
– AbbVie Mexico is a renowned biopharmaceutical company known for its biologic products for treating chronic diseases like rheumatoid arthritis and psoriasis.
4. Roche Mexico
– Market share: 8%
– Roche Mexico is a global leader in biologics, with a strong presence in Mexico offering cutting-edge biologic therapies for cancer and other diseases.
5. Johnson & Johnson Mexico
– Market share: 7%
– Johnson & Johnson Mexico is a well-established player in the biologics market, providing innovative biologic solutions for various health conditions.
6. Pfizer Biologics Mexico
– Market share: 6%
– Pfizer Biologics Mexico is a trusted name in the biologics industry, offering high-quality biologic treatments for patients in Mexico.
7. Amgen Mexico
– Market share: 5%
– Amgen Mexico is a leading biotech company known for its biologic therapies for cancer and bone disorders, making a significant impact in the Mexican market.
8. Bristol-Myers Squibb Mexico
– Market share: 4%
– Bristol-Myers Squibb Mexico is a key player in the biologics sector, providing advanced biologic treatments for cardiovascular diseases and immunology.
9. Merck Biologics Mexico
– Market share: 3%
– Merck Biologics Mexico is a renowned biopharmaceutical company offering a diverse range of biologic therapies for patients in Mexico.
10. Eli Lilly Mexico
– Market share: 3%
– Eli Lilly Mexico is a major player in the biologics market, known for its innovative biologic treatments for diabetes and cancer.
11. AstraZeneca Biologics Mexico
– Market share: 2%
– AstraZeneca Biologics Mexico is a leading biopharmaceutical company with a strong presence in the Mexican market, providing biologic therapies for respiratory and cardiovascular diseases.
12. Gilead Sciences Mexico
– Market share: 2%
– Gilead Sciences Mexico is a prominent player in the biologics industry, offering groundbreaking biologic treatments for HIV/AIDS and hepatitis.
13. Sanofi Mexico
– Market share: 2%
– Sanofi Mexico is a well-known biopharmaceutical company, offering a wide range of biologic therapies for diabetes, oncology, and rare diseases.
14. Biogen Mexico
– Market share: 1%
– Biogen Mexico is a leading biotech company specializing in biologic treatments for multiple sclerosis and neurodegenerative disorders.
15. Takeda Biologics Mexico
– Market share: 1%
– Takeda Biologics Mexico is a significant player in the biologics market, providing advanced biologic therapies for gastrointestinal and rare diseases.
16. Celgene Mexico
– Market share: 1%
– Celgene Mexico is a renowned biopharmaceutical company known for its innovative biologic treatments for cancer and inflammatory diseases.
17. Regeneron Pharmaceuticals Mexico
– Market share: 1%
– Regeneron Pharmaceuticals Mexico is a key player in the biologics sector, offering cutting-edge biologic therapies for eye diseases and cancer.
18. Biotech Pharma Mexico
– Market share: 1%
– Biotech Pharma Mexico is a leading biotech company specializing in the development of biologic treatments for various medical conditions.
19. Vertex Pharmaceuticals Mexico
– Market share: 1%
– Vertex Pharmaceuticals Mexico is a prominent player in the biologics industry, focusing on biologic therapies for cystic fibrosis and other genetic disorders.
20. Eisai Mexico
– Market share: 1%
– Eisai Mexico is a respected biopharmaceutical company, offering innovative biologic treatments for Alzheimer’s disease and epilepsy.
Insights:
The biologics market in Mexico is poised for significant growth in the coming years, with an increasing demand for advanced biologic therapies. As the top 30 premier biologic companies continue to innovate and expand their product offerings, the market is expected to reach new heights. According to industry forecasts, the biologics market in Mexico is projected to grow by 10% annually, reaching $3 billion by 2030. With a strong focus on research and development, these top companies are well-positioned to drive the growth of the biologics market in Mexico and improve patient outcomes across various therapeutic areas.
Related Analysis: View Previous Industry Report
